Pharmacological investigation of gamma aminobutyric acid (GABA) and the development of amygdala-kindled seizures in the rat.
D015097:3-Mercaptopropionic Acid / Q000494:pharmacology; D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000614:Aminocaproates / Q000494:pharmacology; D000679:Amygdala / Q000502:physiology* / Q000503:physiopathology; D000818:Animals; D001640:Bicuculline / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007696:Kindling, Neurologic / Q000187:drug effects*; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000503:physiopathology*; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D015097:3-Mercaptopropionic Acid; D000612:4-Aminobutyrate Transaminase; D000614:Aminocaproates; D001640:Bicuculline; D007093:Imidazoles; D010424:Pentobarbital; D010852:Picrotoxin; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid; C005954:imidazoleacetic acid